Under the leadership of the China Association for Vaccines, CPIVC will build an information sharing platform for the domestic and international vaccine industry.
CPIVC will hold the Inaugural Meeting of the CPIVC & Seminar on the International Vaccine Cooperation Ecosystem online on January 15, 2023.
Lance E Rodewald
Dr. Lance E Rodewald, is a Senior Advisor with the National Immunization Program of China CDC, a position he has held since 2018. From 2012 through 2017 he served as the team lead for the Expanded Program on Immunization in the World Health Organization China Country Office. For the 17 previous years, Dr. Rodewald served with the U.S. Centers for Disease Control and Prevention’s Immunization Services Division, which administers the public sector U.S. immunization program – initially as Associate Director for Science, and from 2000 to 2012 as Director. His long-time research interest has been on improving children’s access to vaccines.
Jian DONG
Jian DONG has 30 years of experience in biomanufacturing, quality control and process development in China and the US. He is the CEO of WuXi Vaccines and Head of Global Engineering of WuXi Biologics. And he was previously the Deputy General Manager of Shanghai United Cell Biotechnology, Senior Process Engineer of Eli Lilly & Co., and Vice Chief Engineer of Shenzhen Kangtai Biological Products. He led China’s first certification of a GMP biologics Drug Substance (DS) and Drug Product (DP) facility in China through both the US FDA PLI and EU EMA. He also led the design, construction, validation and delivery of various WuXi Biologics R&D and manufacturing sites around the world. During his tenure in China, he made significant contributions to his company by obtaining a new drug certificate, four registered approval numbers for biologics, and four GMP certificates. He also acted as Shenzhen Kangtai Biological Products’ lead in the technology transfer, process validation and commercial production of Merck’s yeast-recombinant hepatitis B vaccine in China.
Melanie Saville
Dr. Melanie Saville is the Executive Director of Vaccine Research and Development and the Chief Representative of the CEPI Shanghai Representative Office. She leads the technical teams supporting the vaccine development and enabling science projects funded by CEPI. Melanie is a physician specialized in virology with 20 years of experience in the development and licensure of vaccines for the developed and developing world. In the vaccine industry, Melanie has held positions of increasing responsibility in research and development working for Wyeth, Sanofi Pasteur and Janssen vaccines and prevention. Over the years, she has contributed to the development and licensure of several vaccines for seasonal and pandemic influenza, pediatric combinations, Rabies, Japanese Encephalitis, Dengue and Ebola vaccine across the European, US and international markets. Prior to her involvement in the industry, she was a clinical virologist for the UK Health Protection Agency. She also obtained her medical degree from the University College London.
Yuan Yuan
Yuan Yuan is the China Country Representative at PATH’s Shanghai Representative Office. She is responsible for managing PATH’s partnerships in China, and providing management and business development support for PATH in China. She joined PATH in January 2007 and has served in various roles including as a project manager, administrative and financial officer and more. Having worked in the vaccine field for 15 years, she has participated in the WHO prequalification of the JE vaccine, the development of the rotavirus vaccine, the development and training of the pneumococcal conjugate vaccine, the overseas clinical for OPV, international standard formulation for Sabin IPV D antigen, the HPV vaccine prequalification and other projects. She is familiar with the vaccine development life cycle, including in production, quality, clinical, regulatory, pharmacovigilance, biosafety and various other aspects. Prior to joining PATH, she was a project manager at Integrity Metals in Singapore, and has worked in Indonesia. Ms. Yuan received her Bachelor of Arts, Master of Business Administration and Master of Public Health degrees from Peking University.
简体中文